Teprotumumab
Records for this ingredient, by country (identity only).
ATC L04AG13 · 10 markets · 11 records
AU 2 records · 1 shown of 1
- 500 mg per mL / per unit basis not statedinjectionTEPEZZA teprotumumab 500 mg injection powder vial
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
US 1 records · 1 shown of 1
- 500 mg per mL / per unit basis not statedinjectionTEPEZZA
GB 1 records · 1 shown of 1
- 500 mg per mL / per unit basis not statedinjectionTepezza 500mg powder for concentrate for solution for infusion vials
CA 1 records · 1 shown of 1
- 500 mgpowderTEPEZZA
SG 1 records · 1 shown of 1
- 500 mg/vial per mL / per unit basis not statedinjectionTEPEZZA POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 500 MG/VIAL
TW 1 records · 0 shown of 0
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
HK 1 records · 0 shown of 0
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
JP 1 records · 1 shown of 1
- 500 mg per mL / per unit basis not statedinjectionテッペーザ点滴静注用500mg
EU 1 records · 0 shown of 0
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.
| Strength / form / release | US | GB | CA | AU | SG | TW | HK | JP | EU |
|---|---|---|---|---|---|---|---|---|---|
| 500 mg per mL / per unit basis not stated cannot compare injection | TEPEZZA | Tepezza 500mg powder for concentrate for solution for infusion vials | TEPEZZA teprotumumab 500 mg injection powder vial | テッペーザ点滴静注用500mg | |||||
| 500 mg/vial per mL / per unit basis not stated cannot compare injection | TEPEZZA POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 500 MG/VIAL | ||||||||
| 500 mg powder | TEPEZZA | ||||||||
unknown | TEPEZZA | TEPEZZA POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 500MG | TEPEZZA | ||||||
injection | TEPEZZA for 適目達注射劑 |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
2 more strength/form rows are recorded only in CA · SG and are not shown in this table. Hay 2 filas de concentración/forma registradas solo en CA · SG que no se muestran en esta tabla. 另有 2 个规格/剂型仅在 CA · SG 有记录（未在本表显示）。 另有 2 個規格/劑型僅在 CA · SG 有記錄（未在本表顯示）。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.